{"dosage_and_administration":["SOLUTION SHOULD BE DILUTED WITH APPROPRIATE MEDIUM PRIOR TO I.V. INJECTION 1 VIAL CONTAINS 1.2 G RIBAVIRIN IN 12 ML"],"effective_time":"20171206","id":"f9b3b22d-44aa-4670-9c79-58a420675c5b","inactive_ingredient":["MONOBASIC POTASSIUM PHOSPHATE, DIBASIC SODIUM PHOSPHATE, SODIUM HYDROXIDE OR HYDROCHLORIC ACID (PH ADJUSTMENT), WATER FOR INJECTION"],"keep_out_of_reach_of_children":["KEEP OUT OF REACH OF CHILDREN"],"openfda":{},"package_label_principal_display_panel":["Virazole Injection Label 70007424C FINAL PROOF_Page_1"],"set_id":"b5bb87bd-f3ee-416e-8743-6c3d375b726d","spl_product_data_elements":["VIRAZOLE RIBAVIRIN RIBAVIRIN RIBAVIRIN POTASSIUM PHOSPHATE, MONOBASIC SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM SODIUM HYDROXIDE HYDROCHLORIC ACID WATER"],"storage_and_handling":["STORE AT 25°C (77°F); EXCURSIONS PERMITTED TO 15°C - 30°C (59°F - 86°F)."],"version":"1","warnings_and_cautions":["CAUTION: NEW DRUG - LIMITED BY FEDERAL LAW TO INVESTIGATIONAL USE."]}